Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Leef BrandsLEEEF +8.48%29 3-Year EPS without NRI Growth Rate is 42.70% as of Jun. 2026, which is 144% above its 10-year median of 17.50. GuruFocus rates LEEEF with a GF Score™ of 29/100 and a GF Value™ of $0.11 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 785 Drug Manufacturers companies, Leef Brands ranks better than 85.1% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was 42.70% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 21.80% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 15.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Leef Brands was 63.30% per year. The lowest was -23.50% per year. And the median was 17.50% per year.
Leef Brands (OTCPK:LEEEF) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Leef Brands 3-Year EPS without NRI Growth Rate Related Terms
LEEEF vs ZTS: 3-Year EPS without NRI Growth Rate Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Leef Brands's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Leef Brands 3-Year EPS without NRI Growth Rate vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Leef Brands's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Leef Brands's 3-Year EPS without NRI Growth Rate falls into.
Leef Brands 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 42.70% mean?
Leef Brands (LEEEF) has a 3-Year EPS without NRI Growth Rate of 42.70% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Leef Brands and its competitors. This is 144% above median its historical median of 17.50. According to the industry distribution chart, Leef Brands ranks #117 out of 785 companies in the Drug Manufacturers industry, placing it in the top 14.9%.
Is Leef Brands' 3-Year EPS without NRI Growth Rate too high?
Leef Brands' current 3-Year EPS without NRI Growth Rate of 42.70% is 144% above median its 10-year median of 17.50. The Drug Manufacturers industry median 3-Year EPS without NRI Growth Rate is 9.70. Leef Brands' value of 42.70% is 340.2% above this industry median. Based on the distribution chart, Leef Brands ranks #117 out of 785 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Leef Brands has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Leef Brands' 3-Year EPS without NRI Growth Rate compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Leef Brands ranks #117 out of 785 companies for 3-Year EPS without NRI Growth Rate. This places Leef Brands in the top 15% of its industry — outperforming the majority of peers. The industry median 3-Year EPS without NRI Growth Rate is 9.70. Leef Brands' value of 42.70% is 340.2% above this benchmark. While the company's 10-year median is 17.50 vs. the industry median of 9.70, Leef Brands has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Drug Manufacturers company?
The median 3-Year EPS without NRI Growth Rate among Drug Manufacturers companies is 9.70, based on 785 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Leef Brands's current 3-Year EPS without NRI Growth Rate of 42.70% is 340.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Leef Brands and its competitors. For the Drug Manufacturers industry, the median 3-Year EPS without NRI Growth Rate is 9.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leef Brands's current 3-Year EPS without NRI Growth Rate is 42.70%, which is 144% above median its own 10-year median of 17.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leef Brands stock overvalued right now?
Based on GuruFocus' analysis, Leef Brands (LEEEF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.11, compared to a current price of $0.22 — trading 99.3% above its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 42.70%, which is 144% above median its 10-year median of 17.50 and 340.2% above the Drug Manufacturers industry median of 9.70. Leef Brands' overall GF Score™ is 29/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Leef Brands (LEEEF), the current 3-Year EPS without NRI Growth Rate is 42.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Leef Brands (LEEEF) Overvalued in 2026?
Based on GuruFocus' analysis, Leef Brands stock appears to be overvalued.
The current stock price of $0.22 is trading 99.3% above its estimated GF Value™ of $0.11.
GuruFocus considers Leef Brands to be Significantly Overvalued.
Key valuation signals for LEEEF:
3-Year EPS without NRI Growth Rate: 42.70% (144% above median its 10-year median of 17.50)
GF Value™: $0.11 vs. price of $0.22 (99.3% above fair value)
Industry Position: 340.2% above the Drug Manufacturers median (#117 of 785)
No single metric tells the full story. See the LEEEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Leef Brands Inc is a vertically integrated cannabis extraction and manufacturing operator based in California. The company operates in two reportable segments: Wholesale concentrates and Retail. The wholesale concentrate segment includes the propagation, nursery, flowering canopy, drying, processing, manufacturing and distribution of cannabis concentrates. The retail segment includes company owned and operated retail cannabis store in the state of California. It derives majority of the revenue from Wholesale concentrates segment.
29GF Score
Get the complete analysis for LEEEF
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LEEEF has been successfully added to your 
